✦ LIBER ✦

P-215 Analysis of xeroderma pigmentosum complementation group D (XPD) in the NATCH trial: a neoadjuvant/adjuvant paclitaxel/carboplatin trial in early non-small-cell lung cancer (NSCLC)

✍ Scribed by Felip, Enriqueta; Massuti, Bartomeu; de Aguirre, Itziar; Alonso, Guillermo; Maestre, Jose; Torres, Antonio; Rodriguez-Paniagua, Manuel; Borro, Jose Maria; Sanchez, Jose Javier; Rosell, Rafael

Book ID: 118571916
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 369 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)92184-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-217 K-ras mutations in serum DNA of ea

P-217 K-ras mutations in serum DNA of early non-small-cell lung cancer (NSCLC) patients (p): A genetic analysis of an ongoing randomized neoadjuvant/adjuvant paclitaxel/carboplatin trial

✍ Manzano, Jose Luis; De Aguirre, Itziar; Botia, Monica; Ramirez, Jose Luis; Massu 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 189 KB

P-224 XPD polymorphisms in cisplatin (ci

P-224 XPD polymorphisms in cisplatin (cis)/vinorelbine (vrb)-treated stage IV non-small-cell lung cancer (NSCLC) patients (p): genetic analysis of a Spanish Lung Cancer Group phase II trial

✍ Vin˜olas, Nuria; Roig, Barbara; Reguart, Noemi; Provencio, Mariano; Cardenal, Fe 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 178 KB

O-124 S9900: Preliminary “surgical” resu

O-124 S9900: Preliminary “surgical” results of a phase III trial of surgeryalone or surgery plus preoperative (preop) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC)

✍ Vallieres, E.; Pisters, K.; Crowley, J.; Chansky, K.; Bunn, P.; Gandara, D. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 146 KB

P-252 Elderly patient subset analysis fr

P-252 Elderly patient subset analysis from the randomized trial of three different schedules of weekly paclitaxel in combination with carboplatin for advanced and metastatic non-small cell lung cancer (NSCLC)

✍ Belani, Chandra P.; Ramalingam, Suresh; Barstis, J.; Perry, M.C.; LaRocca, R.V.; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 184 KB

O-086a Randomized phase II/III trial of

O-086a Randomized phase II/III trial of paclitaxel (P) plus carboplatin (C)with or without bevacizumab (NSC #704865) in patients with advanced non-squamous non-small cell lung cancer (NSCLC): An Eastern Cooperative Oncology Group (ECOG) Trial — E4599

✍ Sandler, A.B.; Gray, R.; Brahmer, J.; Dowlati, A.; Schiller, J.H.; Perry, M.C.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 151 KB

92 POSTER Effects of AZD2171 on pharmaco

92 POSTER Effects of AZD2171 on pharmacokinetics (PK) of carboplatin (C) and paclitaxel (P) in patients with advanced non-small cell lung cancer (NSCLC): a study of the National Cancer Institute of Canada Clinical Trials Group

✍ E. Chen; W. Zhang; S. Lauri; A. Arnold; I. Gauthier; G. Goss; P. Ellis; F. Sheph 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 57 KB